UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Severe Abdominal Aortic Calcification in Older Men Is Negatively Associated With DKK1 Serum Levels: The STRAMBO Study

The journal of clinical endocrinology and metabolism, 2014-02, Vol.99 (2), p.617-624

2014

Volltextzugriff (PDF)

p38 MAPK regulates the Wnt inhibitor Dickkopf-1 in osteotropic prostate cancer cells

Cell death & disease, 2016-02, Vol.7 (2), p.e2119-e2119

2016

Volltextzugriff (PDF)

Prospects of adjuvant RANKL inhibition in breast cancer?

Cell death & disease, 2015-11, Vol.6 (11), p.e1982-e1982

2015

Volltextzugriff (PDF)

1054 Blood-based detection of circulating dickkopf-1 as a prognostic biomarker in ovarian cancer patients

International journal of gynecological cancer, 2021-10, Vol.31 (Suppl 3), p.A294-A294

2021

Volltextzugriff (PDF)

Seizures after treatment with zoledronic acid for osteoporosis

Bone (New York, N.Y.), 2011-05, Vol.48, p.S219-S219

2011

Volltextzugriff (PDF)

5097 POSTER Modulation of Proliferation in MCF7 Cells by Regulated Expression of KLF2, 4, 6 and Ki-67 After Treatment With Zoledronic Acid

European journal of cancer (1990), 2011, Vol.47, p.S359-S359

2011

Volltextzugriff (PDF)

Osteoporosis: now and the future

The Lancet (British edition), 2011-04, Vol.377 (9773), p.1276-1287

2011

Volltextzugriff (PDF)

Bone health during endocrine therapy for cancer

The lancet. Diabetes & endocrinology, 2018-11, Vol.6 (11), p.901-910

2018

Volltextzugriff (PDF)

Calcium and osteoprotegerin regulate IGF1R expression to inhibit vascular calcification

Cardiovascular research, 2011-08, Vol.91 (3), p.537-545

2011

Volltextzugriff (PDF)

Bone metastases : New aspects of pathogenesis and systemic therapy

Der Internist (Berlin), 2016-07, Vol.57 (7), p.666-674

2016

Volltextzugriff (PDF)

Denosumab effects on bone density and turnover in postmenopausal women with low bone mass with or without previous treatment

Bone (New York, N.Y.), 2019-03, Vol.120, p.44-49

2019

Volltextzugriff (PDF)

Abstract P6-09-08: High circulating levels of Periostin are associated with a poor survival in primary, non-metastatic breast cancer patients

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P6-P6-09-08

2019

Volltextzugriff (PDF)

Abstract P6-09-01: In primary, non-metastatic breast cancer patients, increased serum levels of RANKL significantly correlate with tumor cell spread to the bone and the occurrence of bone metastasis whereas high levels of its soluble decoy receptor osteoprotegerin predict poor survival

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P6-P6-09-01

2019

Volltextzugriff (PDF)

Novel therapies in benign and malignant bone diseases

Pharmacology & therapeutics (Oxford), 2012-06, Vol.134 (3), p.338-344

2012

Volltextzugriff (PDF)

Effect of zoledronic acid exposure on Ki-67 expression and proliferation in MCF7 cells resistant to apoptosis induction

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e21129-e21129

2011

Volltextzugriff (PDF)

Abstract P6-07-11: Serum levels of RANKL are increased in primary breast cancer patients in the presence of disseminated tumor cells in the bone marrow

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P6-P6-07-11

2017

Volltextzugriff (PDF)

Die Rolle der Wnt-Inhibitoren Sklerostin und Dickkopf-1 bei Erkrankungen des Knochens

Osteologie, 2016, Vol.25 (3), p.198-203

2016

Volltextzugriff (PDF)

Osteoprotegerin production by breast cancer cells is suppressed by dexamethasone and confers resistance against TRAIL-induced apoptosis

Journal of cellular biochemistry, 2009-09, Vol.108 (1), p.106-116

2009

Volltextzugriff (PDF)

Unknown case 3: subcapsular liver hematoma

Journal of ultrasound in medicine, 1988-11, Vol.7 (11), p.649-649

1988

Volltextzugriff (PDF)

Glycosaminoglycans and their sulfate derivatives differentially regulate the vitality and gene expression of osteocyte-like cell lines

Experimental and clinical endocrinology & diabetes, 2014, Vol.122 (3)

2014

Volltextzugriff (PDF)

Knochenmetastasen: Pathophysiologie und zellbiologische Grundlagen

Osteologie, 2014, Vol.23 (4), p.239-244

2014

Volltextzugriff (PDF)

Knochenmetastasen: Neues zur Pathogenese und systemischen Therapie

Der Internist (Berlin), 2016-07, Vol.57 (7), p.666-674

2016

Volltextzugriff (PDF)

Estrogen-dependent regulation of osteoprotegerin production by breast cancer cells

Geburtshilfe und Frauenheilkunde, 2008-09, Vol.68 (S 01)

2008

Volltextzugriff (PDF)

The MR appearance of endovascular embolic agents in vitro with clinical correlation

Computerized medical imaging and graphics, 1990-11, Vol.14 (6), p.415-423

1990

Volltextzugriff (PDF)

Cholesterol and beyond - The role of the mevalonate pathway in cancer biology

Biochimica et biophysica acta. Reviews on cancer, 2020-04, Vol.1873 (2), p.188351-188351, Article 188351

2020

Volltextzugriff (PDF)

1 – 25 von 164

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(132)
Mit Volltextzugriff
(136)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(157)
Deutsch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Severe Abdominal Aortic Calcification in Older Men Is Negatively Associated With DKK1 Serum Levels: The STRAMBO Study

p38 MAPK regulates the Wnt inhibitor Dickkopf-1 in osteotropic prostate cancer cells

Prospects of adjuvant RANKL inhibition in breast cancer?

1054 Blood-based detection of circulating dickkopf-1 as a prognostic biomarker in ovarian cancer patients

Seizures after treatment with zoledronic acid for osteoporosis

5097 POSTER Modulation of Proliferation in MCF7 Cells by Regulated Expression of KLF2, 4, 6 and Ki-67 After Treatment With Zoledronic Acid

Osteoporosis: now and the future

Bone health during endocrine therapy for cancer

Calcium and osteoprotegerin regulate IGF1R expression to inhibit vascular calcification

Bone metastases : New aspects of pathogenesis and systemic therapy

Denosumab effects on bone density and turnover in postmenopausal women with low bone mass with or without previous treatment

Abstract P6-09-08: High circulating levels of Periostin are associated with a poor survival in primary, non-metastatic breast cancer patients

Abstract P6-09-01: In primary, non-metastatic breast cancer patients, increased serum levels of RANKL significantly correlate with tumor cell spread to the bone and the occurrence of bone metastasis whereas high levels of its soluble decoy receptor osteoprotegerin predict poor survival

Novel therapies in benign and malignant bone diseases

Effect of zoledronic acid exposure on Ki-67 expression and proliferation in MCF7 cells resistant to apoptosis induction

Abstract P6-07-11: Serum levels of RANKL are increased in primary breast cancer patients in the presence of disseminated tumor cells in the bone marrow

Die Rolle der Wnt-Inhibitoren Sklerostin und Dickkopf-1 bei Erkrankungen des Knochens

Osteoprotegerin production by breast cancer cells is suppressed by dexamethasone and confers resistance against TRAIL-induced apoptosis

Unknown case 3: subcapsular liver hematoma

Glycosaminoglycans and their sulfate derivatives differentially regulate the vitality and gene expression of osteocyte-like cell lines

Knochenmetastasen: Pathophysiologie und zellbiologische Grundlagen

Knochenmetastasen: Neues zur Pathogenese und systemischen Therapie

Estrogen-dependent regulation of osteoprotegerin production by breast cancer cells

The MR appearance of endovascular embolic agents in vitro with clinical correlation

Cholesterol and beyond - The role of the mevalonate pathway in cancer biology

Suchergebnisse filtern